CCc1ccc(-n2c(=O)c3c(C)c(C)sc3n(CC(=O)NCc3ccc(C)cc3)c2=O)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?